A Phase 2/3 Multicenter, Controlled Trial Of rhBMP-2/CPM In Tibial Fractures

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00387686
Recruitment Status : Terminated (Decision was taken by Wyeth Sr. Management to early terminate the 3100N7-210 study (terminate enrollment but complete follow-up).)
First Posted : October 13, 2006
Last Update Posted : February 28, 2013
Information provided by (Responsible Party):
Wyeth is now a wholly owned subsidiary of Pfizer

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 2009
  Actual Study Completion Date : March 2010
  Certification/Extension First Submitted : February 21, 2013